Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2010
11/17/2010CN101885770A Fully human antibody capable of specifically bonding CD15 and use thereof
11/17/2010CN101885769A Fully human antibody capable of specifically bonding CD4 and use thereof
11/17/2010CN101885731A Thiophene derivative
11/17/2010CN101885726A New compound structure and preparation method and application thereof
11/17/2010CN101885722A Heterocycle alkyne and benzene compound, medicinal composition and application thereof
11/17/2010CN101885709A Novel thiazole amine compound and synthesis thereof
11/17/2010CN101885689A Fat soluble dual-core cobalt (III) anti-tumor coordination compound and preparation method thereof
11/17/2010CN101884811A Bone grafting material of gradient porous beta-TCP with bioactivity and anti-infection effect, preparation method and application thereof
11/17/2010CN101884791A Latrozole co-ground material, preparation method thereof and medicament composition having same
11/17/2010CN101884784A Bv8 nucleic acids and polypeptides with mitogenic activity
11/17/2010CN101884780A Use of hepcidin as a regulator of iron homeostasis
11/17/2010CN101884752A Chinese medicinal preparation for navel plaster and preparation method thereof
11/17/2010CN101884719A Traditional Chinese medicine for treating various squamous-cell carcinomas and preparation method thereof
11/17/2010CN101884717A Traditional Chinese medicine for treating cancer and preparation method thereof
11/17/2010CN101884648A Realgar for treating stomach cancer
11/17/2010CN101884647A Realgar for treating melanoma
11/17/2010CN101884636A Application of corosolic acid in preparation of antineoplastic medicine
11/17/2010CN101884631A Anti-tumor medicament based on alpha ketoglutaric acid and derivatives thereof
11/17/2010CN101884620A Activated carbon granule of load quantum dots as well as preparation method and application thereof
11/17/2010CN101884618A Long-circulating paclitaxel nanoparticles and preparation method thereof
11/17/2010CN101884616A Docetaxel long-circulating liposome and preparation method thereof
11/17/2010CN101884280A Method for planting selenium-enriched food for preventing diseases and resisting cancer
11/17/2010CN101619291B Chaetomium cupreum strain and use thereof
11/17/2010CN101440092B 2-indazole-4-aza indole-5-amino derivatives, and preparation and use thereof
11/17/2010CN101402942B PolyLyse-HSP70 fusion protein film modified intestinal cancer cytoma vaccine and method of producing the same
11/17/2010CN101391056B Medicine for treating aplastic anemia
11/17/2010CN101375860B Application of cisplatin combined with hTERT-HRP/IAA in medicament for treating cervical cancer
11/17/2010CN101370497B Combination product with PARP inhibitors and cell toxin and its uses
11/17/2010CN101361939B Malignant tumor treating medicine
11/17/2010CN101332198B Pharmaceutical use of 6-aryl-3-substituted carbonyl pyridine compound
11/17/2010CN101327317B Injection for treating cancer and its preparation method
11/17/2010CN101311192B Process for high-efficiency expressing sTNFR/Fc fusion protein in yeast and uses thereof
11/17/2010CN101305998B Use of aryl-3-substituted carbonyl pyridone compound
11/17/2010CN101284007B Pharmaceutical use of aryl group substituted pyridone derivates in preparing medicine for tumour
11/17/2010CN101240006B Oleanane triterpene compound with C ring containing conjugated double bond and use thereof
11/17/2010CN101223139B 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
11/17/2010CN101199511B Andrographis lactone self-emulsification capsule of antibacterial antiphlogistic
11/17/2010CN101181321B Effective component of angelica as well as preparation method and application
11/17/2010CN101167821B External-applied traditional Chinese medicine for curing breast cancer and its preparation method
11/17/2010CN101153024B Aryl substituted imidazoline-2-ketones derivant, producing method and uses of the same
11/17/2010CN101129896B Chinese medicinal herb agentia for treating tumour disease
11/17/2010CN101112371B Application of compound s2 in the preparation of anti-cancer medicine
11/17/2010CN101091705B Application of compounds in isorhodanic ester classes for treating diseases of prostate and skin cancer
11/17/2010CN101036741B Medicine for treating cancer and preparing method therefor
11/17/2010CN101035809B Humanized anti-tag-72 monoclonal antibodies
11/17/2010CN101001623B Anticancer effect enhancer
11/16/2010US7834181 Small-molecule Hsp90 inhibitors
11/16/2010US7834180 contacting a picolinic acid derivative with a benzothiazole derivative or tautomers thereof, in the presence of a non-nucleophilic base; compounds inhibit cell proliferation, induce cell apoptosis and stabilize a quadruplex structure
11/16/2010US7834179 6',7',8',9'-tetrahydro spiro[3H-indole-3,7'-(2H-pyrido[2,1-c][1,2,4]triazine)]-2,3'(1H)-dione compounds; small molecule inhibitors of the MDM2-p53 interaction
11/16/2010US7834141 Antiproliferative agents; gonadotropin releasing factor; binding to tumor and cancer cells; Chicken II GnRH analog; resistant to degradation by post-proline peptidases
11/16/2010US7834049 Integrin expression inhibitor
11/16/2010US7834033 administering a tumor necrosis factor inhibitor; angiogenesis inhibitor; treating inflammatory, and autoimmune diseases
11/16/2010US7834029 For therapy of cancer; treating prostate cancer with 2-(6-methyl-pyridin-2-yl)-3-[6-amido-quinolin-4-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole; TGF-beta signal transduction inhibitors
11/16/2010US7834022 enzyme inhibitor for treating immune-related diseases, skin disorders, myeloid proliferative disorders, cancer; allograft rejection or graft versus host disease
11/16/2010US7834019 3-(2-allyl-6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-3-oxo-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-1-yl)-N,N-dimethylbenzamide; Weel kinase inhibitor; treatment of various cancers; composition with other anticancer agents
11/16/2010US7834016 breast cancer, prostate cancer, and colon cancer; indole, indoline, indol-2-one, or benzimidazoline based compounds having arylamine groups, for example 1-(pyrid-4-ylamino)-4-(2-(indol-3-yl)ethylamino)benzene
11/16/2010US7833997 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability
11/16/2010US7833991 Amine compound and use thereof
11/16/2010US7833976 administering an antitumor agent containing a combination of an alpha v beta 3 angiogenisis antagonist and an anti-tumor immunotherapeutic agent, which is a fusion protein of a cytokine IL-2 and an Ig heavy chain that immunoreacts with a tumor associated antigen target; drug target
11/16/2010US7833538 using an immunostimulatory dinucleotide of formula CpG*, wherein C is a natural or non-natural pyrimidine nucleoside and G* is 7-deazaguanosine; for treating autoimmune disorders, such as autoimmune asthma; allergies
11/16/2010US7833532 synthetic molecules comprising co-linear T-helper and CTL epitopes; enhanced ability to activate a T cell response to a CD8+ T cell epitope to induce cell mediated immunity against an invading pathogen or tumour cell
11/16/2010US7833525 Crystals of whole antibodies and fragments thereof and methods for making and using them
11/16/2010CA2523216C Recombinant alphavirus vectors
11/16/2010CA2477474C Cyclic n-substituted alpha imino carboxylic acids for selective inhibition of collagenase
11/16/2010CA2471220C Novel alkansulfonamides as endothelin antagonists
11/16/2010CA2436846C Thioether substituted imidazoquinolines
11/16/2010CA2422622C Novel baff-r nucleic acids and polypeptides
11/16/2010CA2415643C Pharmaceutical composition for oral use with improved absorption
11/16/2010CA2405704C Bombesin analogs for treatment of cancer
11/16/2010CA2389165C Substituted indoles for modulating nfkb activity
11/16/2010CA2367240C Treatment of accidental extravasation of anthracyclines
11/16/2010CA2330659C Using ngali nut oil to treat/relieve manifestations of arthritis and other similar conditions
11/16/2010CA2311648C Ifnar2/ifn complex
11/16/2010CA2240339C [3'-desoxy-3'-oxo-mebmt]1-[val]2-ciclosporin-containing emulsion pharmaceutical composition
11/11/2010WO2010129947A2 Alpha thymosin peptides as vaccine enhancers
11/11/2010WO2010129918A1 Triptolide prodrugs
11/11/2010WO2010129917A2 Anti-cd100 antibodies and methods for using the same
11/11/2010WO2010129895A2 Cd133 epitopes
11/11/2010WO2010129789A2 Modified tumor necrosis factor-beta
11/11/2010WO2010129752A1 Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both
11/11/2010WO2010129740A1 Use of osi-906 for treating adrenocortical carcinoma
11/11/2010WO2010129620A1 Imidazo [ 1, 2 -a] pyridin-2 -yl-phenyl derivatives to be used in cancer treatment
11/11/2010WO2010129596A1 Pmk2 modulators for use in the treatment of cancer
11/11/2010WO2010129570A1 Solid forms of sulfonamides and amino acids
11/11/2010WO2010129567A1 Pyrrolo [2, 3. b] pyridines which inhibit raf protein kinase
11/11/2010WO2010129340A2 Novel photosensitizer formulations for oral administration
11/11/2010WO2010129339A2 Compositions and methods for enhancing antigen-specific immune responses
11/11/2010WO2010129337A2 New oral formulations for tetrapyrrole derivatives
11/11/2010WO2010129053A2 Egfr inhibitors and methods of treating disorders
11/11/2010WO2010129048A2 Therapeutic compounds
11/11/2010WO2010128807A2 Pharmaceutical composition for preventing or treating neuronal damage and neurological diseases
11/11/2010WO2010128685A1 Alpha helix mimetics and methods relating thereto
11/11/2010WO2010128659A1 Diamino heterocyclic carboxamide compound
11/11/2010WO2010128443A1 Pyrrolidine-substituted flavones as radio-sensitizers for use in the treatment of cancer
11/11/2010WO2010128309A1 Combination therapy comprising a taxane and a sigma receptor ligand sauch as rimcazole
11/11/2010WO2010128259A1 Antitumor combination including ave8062 and sorafenib
11/11/2010WO2010128258A1 Antitumor combination including cabazitaxel and capecitabine
11/11/2010WO2010127754A1 3-([1,2,3]triazole-4-yl)-pyrrolo[2,3-b]pyridine derivates
11/11/2010WO2010127704A1 Beta-hairpin peptidomimetics having cxcr4 antagonizing activity
11/11/2010WO2010127608A1 Heterocyclic substituted acardite derivates and use thereof
1 ... 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 ... 2211